http://orcid.org/0000-0002-8620-9424
References
- Lippert S, Goetze JP. C-type natriuretic-derived peptides as biomarkers in human disease. Biomark Med. 2010;4:631–639.
- Zhifen Z, Salmassi A, Mettler L. Expression of macrophage clolony-stimulating factor in human luteinized granulosa cells. Chin J Obstet Gynecol. 2002;08:27–29.
- Zhang M, Su Y-Q, Sugiura K, et al. Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes. Science. 2010;330:366–369.
- Sato Y, Cheng Y, Kawamura K, et al. C-type natriuretic peptide stimulates ovarian follicle development. Mol Endocrinol. 2012;26:1158–1166.
- Miyazawa T, Ogawa Y, Chusho H, et al. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology. 2002;143:3604–3610.
- Robinson JW, Zhang M, Shuhaibar LC, et al. Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes. Dev Biol. 2012;366:308–316.
- Wang Y, de Waard MC, Sterner-Kock A, et al. Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail. 2007;9:548–557.